Keyphrases
Local Inhibition
100%
Procoagulant Activity
100%
Small Diameter
100%
Tissue Engineered Vascular Graft
100%
Fibrinopeptide A
75%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
75%
Hirudin
75%
Antithrombotic Agents
75%
Thrombus
50%
Low Flow
50%
Graft Patency
50%
Thrombin
50%
Prosthetic Grafts
50%
Control Agents
50%
Anticoagulant Peptide
50%
Collagen
25%
Heparin
25%
Perfusion
25%
Factor Xa
25%
Tissue Factor
25%
Factor VIIa
25%
Antithrombin III (ATIII)
25%
Factor IIa
25%
Antithrombin Activity
25%
Fibrin Formation
25%
Local Application
25%
Fibrin
25%
Systemic Administration
25%
Activated Factor X
25%
Human Plasma
25%
Saline Solution
25%
Multi-well Plate
25%
No-flow
25%
L-Arg
25%
Inhibitor Solution
25%
Medicine and Dentistry
Rehabilitation Engineering
100%
Procoagulant
100%
Blood Vessel Graft
100%
Thrombin
75%
Tissue Factor Pathway Inhibitor
75%
Antithrombotic Agent
75%
Hirudin
75%
Thrombus
50%
Graft Patency
50%
Tick Anticoagulant Peptide
50%
Fibrinopeptide
50%
Health Care Cost
25%
Antithrombin III
25%
Fibrin Formation
25%
Prothrombinase
25%
Fibrinopeptide A
25%
Thromboplastin
25%
Arginine
25%
Heparinization
25%
Systemic Administration
25%
Factor X
25%
Pharmacology, Toxicology and Pharmaceutical Science
Procoagulant
100%
Thrombin
75%
Anticoagulant Agent
75%
Hirudin
75%
Tissue Factor Pathway Inhibitor
75%
Thrombus
50%
Fibrinopeptide
50%
Tick Anticoagulant Peptide
50%
Heparin
25%
Arginine
25%
Thromboplastin
25%
Antithrombin III
25%
Systemic Administration
25%
Blood Clotting Factor 10a
25%
Blood Clotting Factor 10
25%
Fibrinopeptide A
25%